High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer

PURPOSE: The enhancer of zeste homologue 2 (EZH2) is a catalytic subunit of the polycomb repressive complex 2, a highly conserved histone methyltransferase. EZH2 overexpression has been implicated in various malignancies, including breast cancer, where is associated with poor outcomes. This study ai...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Breast Cancer
Main Authors: Jang, Si-Hyong, Lee, Jong Eun, Oh, Mee-Hye, Lee, Ji-Hye, Cho, Hyun Deuk, Kim, Kyung-Ju, Kim, Sung Yong, Han, Sun Wook, Kim, Han Jo, Bae, Sang Byung, Lee, Hyun Ju
Formato: Artigo
Idioma:Inglês
Publicado: Korean Breast Cancer Society 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4822107/
https://ncbi.nlm.nih.gov/pubmed/27066096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2016.19.1.53
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares